Financials
Ventive secures c.£900,000 investment | 06-Nov-2023 | 07:00 | RNS |
Change of Adviser | 02-Nov-2023 | 07:00 | RNS |
Exercise of Options | 13-Oct-2023 | 07:00 | RNS |
Director/PDMR Shareholding | 03-Oct-2023 | 16:12 | RNS |
PDS: Interim 24-month survival rate of 74% update | 03-Oct-2023 | 15:21 | RNS |
Interim Results | 28-Sep-2023 | 07:00 | RNS |
PDS Biotech: 2nd Quarter Results, Business Update | 14-Aug-2023 | 17:55 | RNS |
PDS Biotech: Submission of Phase 3 Protocol to FDA | 14-Aug-2023 | 17:51 | RNS |
Grant of Options, Issue of Shares, Director/PDMR | 03-Jul-2023 | 07:00 | RNS |
DName-iT Holdings Limited Fundraising | 30-Jun-2023 | 07:00 | RNS |
Result of AGM & Board Changes | 29-Jun-2023 | 11:04 | RNS |
Vortex Fundraising | 22-Jun-2023 | 07:00 | RNS |
Director/PDMR Shareholding | 07-Jun-2023 | 07:00 | RNS |
Notice of AGM | 06-Jun-2023 | 07:00 | RNS |
Preliminary Results for the year ended 31 Dec 2022 | 31-May-2023 | 07:01 | RNS |
Currency | UK Pounds |
Share Price | 67.50p |
Change Today | -1.00p |
% Change | -1.46 % |
52 Week High | 72.00 |
52 Week Low | 49.00 |
Volume | 24,921 |
Shares Issued | 23.95m |
Market Cap | £16.16m |
RiskGrade | 410 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
14:10 | 1,499 @ 66.72p |
14:02 | 4,027 @ 66.64p |
10:48 | 766 @ 66.64p |
09:53 | 1,129 @ 67.53p |
08:41 | 12,500 @ 67.84p |
CEO | Ilian Iliev |
CFO | Stephen Crowe |
You are here: research